List of Tables
    Table 1. Primary Antibodies CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Primary Antibodies Market Trends
    Table 3. Primary Antibodies Market Drivers
    Table 4. Primary Antibodies Market Challenges
    Table 5. Primary Antibodies Market Restraints
    Table 6. Global Primary Antibodies Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Primary Antibodies Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Primary Antibodies Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Primary Antibodies Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Primary Antibodies Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Primary Antibodies Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Primary Antibodies Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Primary Antibodies Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Primary Antibodies Sales Share by Manufacturer, 2017-2022
    Table 15. Global Primary Antibodies Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Primary Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Primary Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibodies as of 2021)
    Table 18. Top Players of Primary Antibodies in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Primary Antibodies Product Type
    Table 20. Date of International Manufacturers Enter into Primary Antibodies Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Primary Antibodies Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Primary Antibodies Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Primary Antibodies Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Primary Antibodies Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Primary Antibodies Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Primary Antibodies Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Primary Antibodies Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Primary Antibodies Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Primary Antibodies Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Primary Antibodies Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Primary Antibodies Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Primary Antibodies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Primary Antibodies Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Primary Antibodies Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Primary Antibodies Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Primary Antibodies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Primary Antibodies Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Primary Antibodies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Primary Antibodies Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Primary Antibodies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abcam Corporation Information
    Table 43. Abcam Description and Business Overview
    Table 44. Abcam Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Abcam Primary Antibodies Product
    Table 46. Abcam Recent Development
    Table 47. BD Corporation Information
    Table 48. BD Description and Business Overview
    Table 49. BD Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. BD Product
    Table 51. BD Recent Development
    Table 52. Santa Cruz Biotechnology Corporation Information
    Table 53. Santa Cruz Biotechnology Description and Business Overview
    Table 54. Santa Cruz Biotechnology Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Santa Cruz Biotechnology Product
    Table 56. Santa Cruz Biotechnology Recent Development
    Table 57. Sigma Aldrich Corporation Corporation Information
    Table 58. Sigma Aldrich Corporation Description and Business Overview
    Table 59. Sigma Aldrich Corporation Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Sigma Aldrich Corporation Product
    Table 61. Sigma Aldrich Corporation Recent Development
    Table 62. Thermo Fisher Scientific Corporation Information
    Table 63. Thermo Fisher Scientific Description and Business Overview
    Table 64. Thermo Fisher Scientific Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Thermo Fisher Scientific Product
    Table 66. Thermo Fisher Scientific Recent Development
    Table 67. Bio-Rad Corporation Information
    Table 68. Bio-Rad Description and Business Overview
    Table 69. Bio-Rad Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Bio-Rad Product
    Table 71. Bio-Rad Recent Development
    Table 72. R&D Systems Corporation Information
    Table 73. R&D Systems Description and Business Overview
    Table 74. R&D Systems Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. R&D Systems Product
    Table 76. R&D Systems Recent Development
    Table 77. MBL Corporation Information
    Table 78. MBL Description and Business Overview
    Table 79. MBL Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. MBL Product
    Table 81. MBL Recent Development
    Table 82. CST Corporation Information
    Table 83. CST Description and Business Overview
    Table 84. CST Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. CST Product
    Table 86. CST Recent Development
    Table 87. Merk Corporation Information
    Table 88. Merk Description and Business Overview
    Table 89. Merk Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Merk Product
    Table 91. Merk Recent Development
    Table 92. Novus Biologicals Corporation Information
    Table 93. Novus Biologicals Description and Business Overview
    Table 94. Novus Biologicals Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Novus Biologicals Product
    Table 96. Novus Biologicals Recent Development
    Table 97. PeproTech Corporation Information
    Table 98. PeproTech Description and Business Overview
    Table 99. PeproTech Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. PeproTech Product
    Table 101. PeproTech Recent Development
    Table 102. Cayman Corporation Information
    Table 103. Cayman Description and Business Overview
    Table 104. Cayman Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. Cayman Product
    Table 106. Cayman Recent Development
    Table 107. AbMax Biotechnology Corporation Information
    Table 108. AbMax Biotechnology Description and Business Overview
    Table 109. AbMax Biotechnology Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. AbMax Biotechnology Product
    Table 111. AbMax Biotechnology Recent Development
    Table 112. MABTech Corporation Information
    Table 113. MABTech Description and Business Overview
    Table 114. MABTech Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. MABTech Product
    Table 116. MABTech Recent Development
    Table 117. KPL Corporation Information
    Table 118. KPL Description and Business Overview
    Table 119. KPL Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. KPL Product
    Table 121. KPL Recent Development
    Table 122. Abnova Corporation Information
    Table 123. Abnova Description and Business Overview
    Table 124. Abnova Primary Antibodies Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Abnova Product
    Table 126. Abnova Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Primary Antibodies Customers List
    Table 130. Primary Antibodies Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Primary Antibodies Product Picture
    Figure 2. Global Primary Antibodies Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Primary Antibodies Market Size 2017-2028 (US$ Million)
    Figure 4. Global Primary Antibodies Sales 2017-2028 (K MT)
    Figure 5. United States Primary Antibodies Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Primary Antibodies Market Size 2017-2028 (US$ Million)
    Figure 7. United States Primary Antibodies Sales 2017-2028 (K MT)
    Figure 8. United States Primary Antibodies Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Primary Antibodies Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Primary Antibodies Report Years Considered
    Figure 11. Product Picture of Polyclonal
    Figure 12. Product Picture of Monoclonal
    Figure 13. Global Primary Antibodies Market Share by Type in 2022 & 2028
    Figure 14. Global Primary Antibodies Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Primary Antibodies Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Primary Antibodies Sales by Type (2017-2028) & (K MT)
    Figure 17. Global Primary Antibodies Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Primary Antibodies Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Primary Antibodies Market Share by Type in 2022 & 2028
    Figure 20. United States Primary Antibodies Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Primary Antibodies Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Primary Antibodies Sales by Type (2017-2028) & (K MT)
    Figure 23. United States Primary Antibodies Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Primary Antibodies Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of ELISA
    Figure 26. Product Picture of Western Blot
    Figure 27. Product Picture of Immunostaining
    Figure 28. Product Picture of Immunohistochemistry
    Figure 29. Product Picture of Immunocytochemistry
    Figure 30. Product Picture of Other
    Figure 31. Global Primary Antibodies Market Share by Application in 2022 & 2028
    Figure 32. Global Primary Antibodies Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Primary Antibodies Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Primary Antibodies Sales by Application (2017-2028) & (K MT)
    Figure 35. Global Primary Antibodies Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Primary Antibodies Price by Application (2017-2028) & (USD/MT)
    Figure 37. United States Primary Antibodies Market Share by Application in 2022 & 2028
    Figure 38. United States Primary Antibodies Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Primary Antibodies Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Primary Antibodies Sales by Application (2017-2028) & (K MT)
    Figure 41. United States Primary Antibodies Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Primary Antibodies Price by Application (2017-2028) & (USD/MT)
    Figure 43. North America Primary Antibodies Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 44. North America Primary Antibodies Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Primary Antibodies Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 48. Europe Primary Antibodies Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Primary Antibodies Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 55. Asia-Pacific Primary Antibodies Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Primary Antibodies Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 67. Latin America Primary Antibodies Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Primary Antibodies Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 72. Middle East & Africa Primary Antibodies Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Primary Antibodies Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Primary Antibodies Value Chain
    Figure 77. Primary Antibodies Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed